Terms: = Bone cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Clinical Outcome
6 results:
1. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.
Nelde A; Schuster H; Heitmann JS; Bauer J; Maringer Y; Zwick M; Volkmer JP; Chen JY; Stanger AMP; Lehmann A; Appiah B; Märklin M; Rücker-Braun E; Salih HR; Roerden M; Schroeder SM; Häring MF; Schlosser A; Schetelig J; Schmitz M; Boerries M; Köhler N; Lengerke C; Majeti R; Weissman IL; Rammensee HG; Walz JS
Blood Cancer Discov; 2023 Nov; 4(6):468-489. PubMed ID: 37847741
[TBL] [Abstract] [Full Text] [Related]
2. The clinicopathologic significance of npm1 mutation and ability to detect mutated npm1 by immunohistochemistry in non-AML myeloid neoplasms.
Kaseb H; Visconte V; Socha DS; Crane GM; Durkin L; Cook JR; Maciejewski JP; Hsi ED; Rogers HJ
Genes Chromosomes Cancer; 2023 Oct; 62(10):573-580. PubMed ID: 36959701
[TBL] [Abstract] [Full Text] [Related]
3. CD97 expression is associated with poor overall survival in acute myeloid leukemia.
Vaikari VP; Yang J; Wu S; Alachkar H
Exp Hematol; 2019 Jul; 75():64-73.e4. PubMed ID: 31260716
[TBL] [Abstract] [Full Text] [Related]
4. Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.
Sellar RS; Gale RE; Khwaja A; Garbowski M; Loddo M; Stoeber K; Williams GH; Linch DC
Br J Haematol; 2018 May; 181(4):486-494. PubMed ID: 29676467
[TBL] [Abstract] [Full Text] [Related]
5. Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.
Strickland SA; Shaver AC; Byrne M; Daber RD; Ferrell PB; Head DR; Mohan SR; Mosse CA; Moyo TK; Stricker TP; Vnencak-Jones C; Savona MR; Seegmiller AC
Leuk Res; 2018 Feb; 65():67-73. PubMed ID: 29310020
[TBL] [Abstract] [Full Text] [Related]
6. FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
Whitman SP; Ruppert AS; Radmacher MD; Mrózek K; Paschka P; Langer C; Baldus CD; Wen J; Racke F; Powell BL; Kolitz JE; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
Blood; 2008 Feb; 111(3):1552-9. PubMed ID: 17940205
[TBL] [Abstract] [Full Text] [Related]
